Urine pH: the effects of time and temperature after collection

被引:76
作者
Cook, Janine D.
Strauss, Kathy A.
Caplan, Yale H.
LoDico, Charles P.
Bush, Donna M. [1 ]
机构
[1] Mercy Med Ctr, Dept Pathol, Baltimore, MD 21202 USA
[2] Univ Maryland Baltimore Cty, Sch Med, Dept Epidemiol, Baltimore, MD 21201 USA
[3] Natl Sci Serv, Baltimore, MD 21208 USA
[4] Ctr Substance Abuse Prevent, Substance Abuse & Mental Hlth Serv Admin, Div Workplace Program, Rockville, MD 20857 USA
关键词
D O I
10.1093/jat/31.8.486
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The Mandatory Guidelines for Federal Workplace Drug Testing Programs provide criteria for specimen validity testing, including urine pH cut-offs, to report a urine specimen as adulterated or invalid. Since the urine pH criteria for invalid classifications, ≥ 3 and < 4.5 or ≥ 9 and < 11, became effective in November 2004, a number of specimens with results within the upper invalid limits, typically in the range of 9.1 to 9.3, have been reported with no evidence of adulteration. This study evaluated the hypothesis that these pH findings were the result of exposure to increased environmental temperatures during specimen standing and transport. Indeed, increased storage temperatures were associated with increased urine pH, with the magnitude of the change related to both storage time and temperature. The pH values of specimens stored at -20°C are relatively stable, whereas pH results > 9 are achieved at storage temperatures of room temperature or higher. It is noteworthy that no condition(s) produced a specimen with a pH > 9.5. Degradation of nitrogenous urine analytes is most likely responsible for the noted increases in pH. These findings are intended to supplement information used by the Medical Review Officers who are responsible for interpreting such marginally invalid pH results.
引用
收藏
页码:486 / 496
页数:11
相关论文
共 35 条
  • [1] DETERMINATION OF MORPHINE AND 6-ACETYLMORPHINE IN PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION
    BARRETT, DA
    SHAW, PN
    DAVIS, SS
    [J]. JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1991, 566 (01): : 135 - 145
  • [2] BRERETON DM, 1978, CLIN CHEM, V24, P1420
  • [3] BURTIS CA, 1999, TIETZ TXB CLIN CHEM, P1828
  • [4] Stabilizing drug molecules in biological samples
    Chen, Jiwen
    Hsieh, Yunsheng
    [J]. THERAPEUTIC DRUG MONITORING, 2005, 27 (05) : 617 - 624
  • [5] CHRISTENSON RH, 1985, CLIN CHEM, V31, P448
  • [6] DUFOUR DR, 1999, PROFESSIONAL PRACTIC, P26
  • [7] STABILITY OF DRUGS OF ABUSE IN URINE SAMPLES STORED AT -20-DEGREES-C
    DUGAN, S
    BOGEMA, S
    SCHWARTZ, RW
    LAPPAS, NT
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1994, 18 (07) : 391 - 396
  • [8] ESPOSITO FM, 2006, POST SOFT 2006 ANN M
  • [9] FRASER CG, 1977, CLIN CHEM, V23, P2216
  • [10] FRINGS CS, 1972, CLIN CHEM, V18, P1442